Endüstriler
Showing 481–490 ile ilgili 506 results
-
Lipid-Lowering Drugs Market in China 2021
Amerikan Doları 450The lipid-lowering drugs market in China in terms of revenue is set to grow by US$ 5 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 11.4% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the lipid-lowering drugs market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Rosuvastatin Market in China 2021
Amerikan Doları 450The rosuvastatin market in China in terms of revenue is set to grow by US$ 641 sırasında milyon 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 8.3% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the rosuvastatin market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Cardiovascular Pharmaceutical Market in China 2021
Amerikan Doları 450The cardiovascular pharmaceutical market in China in terms of revenue is set to grow by US$ 7 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 3.3% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the cardiovascular pharmaceutical market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Anti-Infective Pharmaceutical Market in China 2021
Amerikan Doları 450The anti-infective pharmaceutical market in China in terms of revenue is set to grow by US$ 6 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 2.8% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the anti-infective pharmaceutical market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Carbapenem Drug Market in China 2021
Amerikan Doları 450The carbapenem drug market in China in terms of revenue is set to grow by US$ 493 sırasında milyon 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 5.6% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the carbapenem drug market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Biapenem Pharmaceutical Market in China 2021
Amerikan Doları 450In terms of revenue, the biapenem pharmaceutical market in China is projected to grow at a compound annual growth rate (CAGR) ile ilgili 3.2% over the analysis period of 2021 ile 2027, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the biapenem pharmaceutical market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Mono-Ingredient Amoxicillin Pharmaceutical Market in China 2021
Amerikan Doları 450The mono-ingredient amoxicillin pharmaceutical market in China in terms of revenue is set to grow by US$ 924 sırasında milyon 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 3.1% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the mono-ingredient amoxicillin pharmaceutical market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
ADCs for HER2-Expressing Breast Cancer Market in China 2021
Amerikan Doları 450The ADCs for HER2-expressing breast cancer market in China in terms of revenue is set to grow by US$ 373 sırasında milyon 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 96.8% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the ADCs for HER2-expressing breast cancer market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Urothelial Carcinoma (UC) Drug Market in China 2021
Amerikan Doları 450The urothelial carcinoma (UC) drug market in China in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 27.6% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the urothelial carcinoma (UC) drug market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Gastric Cancer Drug Market in China 2021
Amerikan Doları 450The gastric cancer drug market in China in terms of revenue is set to grow by US$ 4 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ile ilgili 10.3% tahmin dönemi boyunca, according to data and analytics company StrategyHelix. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the gastric cancer drug market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
